- Ethics and Philosophy of Science and Technology
- S&E Organizations, Education, Careers and Workforce
- Science, Technology, and Innovation Policy
Aaron D. Levine is an Associate Professor in the School of Public Policy at Georgia Tech and a Guest Researcher in the Division of Reproductive Health at the Centers for Disease Control and Prevention. His research focuses on the intersection between public policy and bioethics. Much of his recent work has examined the development of stem cell science, particularly research using human embryonic stem cells, and the oversight of contentious areas of medicine, such as assisted reproductive technology. In 2012, he received a five-year NSF CAREER award to examine the impact of ethical controversy on graduate science education and the development of scientific careers. Aaron is Co-Director for Engineering Workforce Development for the NSF Engineering Research Center for Cell Manufacturing Technologies (CMaT). He is also the author of Cloning: A Beginner’s Guide (Oneworld Publications, 2007), an accessible introduction to the science of cloning and embryonic stem cells and the ethical and policy controversies this science inspires.
Aaron completed his Ph.D. in Public Affairs at Princeton University, where his dissertation research examined the impact of public policy on the development of human embryonic stem cell science. He also holds an M. Phil. from the University of Cambridge, where, as a Churchill Scholar, he studied computational biology at the Sanger Centre and developed algorithms to help analyze the human genome sequence, and a B.S. in Biology from the University of North Carolina at Chapel Hill, where he was a Morehead Scholar
Journal Article – March 2017
Levine AD, Boulet SL, Kissin DM. Contribution of Assisted Reproductive Technology to Overall Births by Maternal Age in the United States, 2012-2014. JAMA. 2017;317(12):1272-1273. doi:10.1001/jama.2016.21311
Journal Article – February 2015
© 2015 Elsevier Inc. All rights reserved.Several states responded to federal funding limitations placed on human embryonic stem cell research and the potential of the field by creating state stem cell funding programs, yet little is known about the impact of these programs. Here we examine how state programs have affected publication trends in four states.
Cell Stem Cell. 16. Issue 2. 115 - 118. ISSN 1934-5909. DOI 10.1016/j.stem.2015.01.007.
Journal Article – 2015
BMC Biotechnology. 15. Issue 70. BioMed Central. ISSN 1472-6750. DOI 10.1186/s12896-015-0190-4.
Journal Article – March 2010
Over the last couple of decades, oocyte donation has become common, important, and sometimes lucrative. Women who donate eggs are often offered fees, though ostensibly only to offset their expenses and limited to no more than $10,000, following recommendations adopted by the fertility industry. Is the industry adhering to its recommendations? A study of advertisements published in college newspapers raises questions.
Hastings Cent Rep. 40. Issue 2. 25 - 36. United States. ISSN 0093-0334.